Gefitinib-Related Interstitial Lung Disease in Taiwanese Patients With Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gefitinib-Related Interstitial Lung Disease in Taiwanese Patients With Non–Small-Cell Lung Cancer

Published:2013-01 Issue:1 Volume:14 Page:55-61
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Chang Shih-Chieh,Chang Cheng-Yu,Chang Shu-Ju,Yuan Mei-Kang,Lai Yi-Chun,Liu Yu-Chang,Chen Cheng-Yu,Kuo Li-Chiao,Yu Chong-Jen

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial;Kim;Lancet,2008

2. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

3. Severe acute interstitial pneumonia and gefitinib;Inoue;Lancet,2003

4. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study;Kudoh;Am J Respir Crit Care Med,2008

5. Gefitinib in advanced non-small cell lung cancer: clinical experience in patients of Asian origin;Armour;Asia Pac J Clin Oncol,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and risk factors for drug-induced lung injury in hospitalized patients: A matched case-control study;2023-08-03

2. DLCO and Spirometry in non-small cell lung cancer patients receiving EGFR-TKI in Indonesia;Pneumologia;2023-01-01

3. The Dimensions of Reports From Around the World That Address Diversity in Oncology;World Journal of Oncology;2022-10

4. Clinical outcomes and radiation pneumonitis after concurrent EGFR ‐tyrosine kinase inhibitors and radiotherapy for unresectable stage III non‐small cell lung cancer;Thoracic Cancer;2021-01-27

5. Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective;Respiratory Investigation;2018-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3